Che-Kai Tsao, MD

Kai Tsao MD MS is the Medical Director of the Ruttenberg Treatment Center at the Mount Sinai Hospital, and the Medical Director of the Medical Oncology Prostate Cancer Program at the Tisch Cancer Institute.  He is an Associate Professor of Hematology, Oncology, and Medicine at the Icahn School of Medicine at Mount Sinai. He was the Chief Fellow during his Hematology and Oncology fellowship training, and is the recipient of the annual Mount Sinai Hospital Fellow Physician of the year award in 2012. As a physician-clinical investigator specialized in genitourinary cancers, he has authored over 70 peer reviewed paper to date, and is the recipient of several research awards from the American Society of Clinical Oncology (ASCO). His research focus is on the development of biomarkers and novel therapies for Prostate and Kidney cancers. He is the principal investigator of numerous ongoing phase I-III clinical trials. He is currently the reviewer and editor of several urology and oncology peer reviewed journals, and is regularly invited to lecture globally. He is the recipient of Tisch Cancer Institute’s Solid Tumor faculty teacher of the year in 2023.

With focus in improving healthcare delivery, he completed Lean Six Sigma training at Johns Hopkins University in 2017, and completed the Masters of Healthcare Delivery at the Icahn School of Medicine in 2019. He is a disciple of patient-centered care, using a combination of data-driven analytics and LEAN principles in improving cancer care. He has led several international oncology collaborations on behalf of Mount Sinai International, in countries including Vietnam, China, Guyana, and India. In this role since 2017, he has led teams of multi-disciplinary experts in collaboration with international partners to develop healthcare delivery strategy, improve cancer center and hospital infrastructure, implement quality driven process improvement, and prepare for Joint Commission International accreditation.